A new FDA regulatory pathway could accelerate approval of psychedelic therapies for resistant depression and PTSD, and ...
Immix Biopharma Inc. (NASDAQ:IMMX) is one of the best performing NASDAQ stocks according to Wall Street analysts. On March 30 ...
On 4 May 2026, Guardant Health announced that the FDA approved its Guardant360 CDx liquid biopsy as a companion diagnostic for VEPPANU, enabling blood-based detection of ESR1 mutations in ...
Mandara Biopharma Inc. announced approval from the FDA to initiate their clinical trials for the treatment of agitation associated with Alzheimer’s disease. BOULDER ...
A major catalyst window opens for this biopharma stock with Q1 earnings due on May 6, and two key FDA decisions in May and ...
“Launching the clinical trials is an important milestone for Mandara as we advance a potential new therapeutic option for one of the most difficult aspects of caring for patients with Alzheimer’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results